30-Day Postoperative Outcomes in Adults with Obstructive Sleep Apnea Undergoing Upper Airway Surgery
by
, , , and
Samuel Knoedler
1,2,*,†
,
Leonard Knoedler
3,†,
Helena Baecher
1,
Martin Kauke-Navarro
4,
Doha Obed
2,5,
Cosima C. Hoch
6
,
Yannick F. Diehm
2,7,
Peter S. Vosler
8,
Ulrich Harréus
9,
Ulrich Kneser
7
and
Adriana C. Panayi
2,7,* 1
Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, 93053 Regensburg, Germany
2
Division of Plastic Surgery, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
3
Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
4
Department of Surgery, Division of Plastic Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06510, USA
5
Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, 30625 Hannover, Germany
6
Department of Otolaryngology, Head and Neck Surgery, Rechts der Isar Hospital, Technical University Munich, 81675 Munich, Germany
7
Department of Hand-, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, 67071 Ludwigshafen, Germany
8
Head and Neck Cancer Center, Sarasota Memorial Health Care System, Sarasota, FL 34239, USA
9
Department of Otolaryngology, Head and Neck Surgery, Asklepios Hospital, 83646 Bad Toelz, Germany
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Clin. Med. 2022, 11(24), 7371; https://doi.org/10.3390/jcm11247371
Submission received: 21 October 2022
/
Revised: 7 December 2022
/
Accepted: 8 December 2022
/
Published: 12 December 2022
(This article belongs to the Special Issue Current Perspectives on the Treatment of Obstructive Sleep Apnea—Part II)
Abstract
:Background: Obstructive sleep apnea (OSA) is a chronic disorder of the upper airway. OSA surgery has oftentimes been researched based on the outcomes of single-institutional facilities. We retrospectively analyzed a multi-institutional national database to investigate the outcomes of OSA surgery and identify risk factors for complications. Methods: We reviewed the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database (2008–2020) to identify patients who underwent OSA surgery. The postoperative outcomes of interest included 30-day surgical and medical complications, reoperation, readmission, and mortality. Additionally, we assessed risk-associated factors for complications, including comorbidities and preoperative blood values. Results: The study population included 4662 patients. Obesity (n = 2909; 63%) and hypertension (n = 1435; 31%) were the most frequent comorbidities. While two (0.04%) deaths were reported within the 30-day postoperative period, the total complication rate was 6.3% (n = 292). Increased BMI (p = 0.01), male sex (p = 0.03), history of diabetes (p = 0.002), hypertension requiring treatment (p = 0.03), inpatient setting (p < 0.0001), and American Society of Anesthesiology (ASA) physical status classification scores ≥ 4 (p < 0.0001) were identified as risk-associated factors for any postoperative complications. Increased alkaline phosphatase (ALP) was identified as a risk-associated factor for the occurrence of any complications (p = 0.02) and medical complications (p = 0.001). Conclusions: OSA surgery outcomes were analyzed at the national level, with complications shown to depend on AP levels, male gender, extreme BMI, and diabetes mellitus. While OSA surgery has demonstrated an overall positive safety profile, the implementation of these novel risk-associated variables into the perioperative workflow may further enhance patient care.
1. Introduction
Obstructive sleep apnea (OSA) is a chronic disorder defined as increased pharyngeal airway resistance during sleep with subsequent repetitive collapse of the upper airway [1,2]. With over one billion people affected worldwide, OSA represents a highly prevalent and continually increasing disorder. OSA patients suffer from different symptoms, including sleep fragmentation, hypoxia, and increased cardiovascular morbidity [3,4,5,6].
Positive airway pressure (PAP) therapy represents the gold standard in non-surgical OSA management [7]. A wide array of surgical treatment options exist, including (i) uvulopalatopharyngoplasty (UPPP); (ii) other soft tissue reduction procedures, such as tonsillectomy, glossectomy, and epiglottidectomy; (iii) skeletal surgeries, such as maxillomandibular advancement (MMA), genioglossus advancement (GA), and hyoid myotomy and suspension (HMS); and (iv) upper airway bypass procedures, including tracheostomy for severe OSA [1,3].
In most cases, OSA surgeries are performed in non-academic facilities [8]. Outcome research on complication rates and risk-associated factors for OSA is often derived from retrospective analyses of single-surgeon, single-institution, or technique-specific medical records, which can reduce research transferability and significance to the scientific community [9]. By pooling patient data with geographical and institutional variation, an analysis of multicenter national databases can help identify more robust risk-associated factors and provide a panoramic view of postoperative outcomes in OSA patients.
The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) provides an extensive and diverse patient cohort by collecting validated data from more than 700 US hospitals. We, therefore, query this database to fill the research gap regarding the outcomes and occurrence of adverse events of OSA procedures in larger, mostly academic hospital centers, which may represent more complex cases with a multimorbid patient group [10].
2. Methods
2.1. Data Source and Patient Selection
Data were collected between 2008 and 2020 from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. As a multi-institutional catalog, the ACS-NSQIP records over 150 pre-, peri-, and postoperative data points. Since the records analyzed did not contain patient-identifying information, the study was exempt from Institutional Review Board approval.
The ACS-NSQIP database was queried to identify all patients who underwent surgical treatment for obstructive sleep apnea (OSA). Specifically, 13 annual records between 2008 and 2020 were searched for ICD-9-CM 327.23 (“Obstructive sleep apnea”) and ICD-10-CM G47.33 (“Obstructive sleep apnea”) codes. In a second step, we screened this OSA cohort of 4781 cases and retrieved all cases in which bariatric surgical procedures were performed. We excluded a total of 119 cases of bariatric treatment to obtain a more homogeneous cohort undergoing head and neck surgery as the only therapeutic management for OSA. Thus, the analyzed cohort did not include any case of bariatric OSA treatment, either as the main procedure or as a concomitant procedure. Finally, the generated patient pool was manually cross-checked by two investigators (S.K. and A.C.P.), and the classification as head and neck OSA surgery was confirmed for each individual case. A third investigator (L.K.) was consulted in cases of discrepant assessments, with any unclear records being excluded from the analysis.
2.2. Variable Extraction
Pre-, peri-, and thirty-day postoperative variables were extracted for analysis.
(i) Preoperative data were evaluated as follows: (a) patient demographics (sex, age, race, height in inches, and weight in pounds), (b) comorbidities (history of chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF), active dialysis treatment, diabetes mellitus, hypertension, dyspnea, metastatic cancer, smoking status in the past year, steroid or immunosuppressive therapy use, weight loss greater than 10% of body weight, wound infections, ventilator dependency, and functional health status), (c) preoperative scores (wound classification (score of 1–4) and American Society of Anesthesiology (ASA) physical status classification (score of 1–5)), and (d) preoperative laboratory values, including serum sodium, blood urea nitrogen (BUN), serum creatinine, serum albumin, total bilirubin, serum glutamic-oxaloacetic transaminase (SGOT), alkaline phosphatase (ALP), white blood count (WBC), hematocrit, platelet count, partial thromboplastin time (PTT), international normalized ratio (INR), and prothrombin time (PT). In addition, we calculated the body mass index (BMI) for all patients using the following formula: weight (pounds)/height (inches)2 × 703. All extracted preoperative variables are shown in Table 1.
(ii) In terms of perioperative data, we evaluated the type of anesthesia (general, monitored, epidural or spinal, local or regional, and other), surgical specialty (otolaryngology, general surgery, and other), setting (inpatient or outpatient), year of surgery within the 13-year period of 2008–2020, and total operative time in minutes. All perioperative data are shown in Table 2 and Table 3.
For an in-depth evaluation, we manually analyzed all cases of head and neck OSA surgery and first classified them into one of the following types of surgery (based on the most invasive procedure or the entered main procedure): uvulopalatopharyngoplasty (UPPP), palatopharyngoplasty (PPP), tonsillectomy, uvulectomy, partial glossectomy, genioglossus advancement, maxillomandibular advancement, hyoid myotomy and suspension, cases including craniofacial osteotomy, cases including epiglottidectomy, cases including tracheostomy, and other. Next, we refined this classification system by specifying which concomitant (less invasive) procedures were entered in parallel.
When classifying and labeling the individual types of surgery, we closely adhered to the nomenclature recorded in the NSQIP database. Accordingly, the specification of the surgical types was based on the procedural description and the recorded Current Procedural Terminology (CPT) codes. Further, we followed the guidelines of the American Society of Anesthesiologists Task Force on the management of patients with OSA in assessing the invasiveness of the procedures [11]. In rare cases, for example, craniofacial osteotomies, a more precise specification was not possible due to limited case information. Surgical characteristics, including the classification pattern and the prevalence of each (sub)type of surgery, are summarized in Table 3 and Figure 1.
(iii) The gathered and analyzed 30-day postoperative outcomes included discharge destination (home, not home, and other or unknown) and length of hospital stay (LOS). LOS was counted as the difference in days between the date of admission and the date of discharge. Any complication was defined as the occurrence of any of the following: mortality, reoperation, readmission or unplanned readmission, and surgical or medical complications. For further analyses, all surgical complications reported in the ACS-NSQIP database (i.e., superficial and deep incision-site infections, organ-space infections, wound lacerations or dehiscences, and blood transfusions) that arose at least once were considered. Similarly, while evaluating all medical complications captured in the ACS-NSQIP catalog (i.e., pulmonary embolism, pneumonia, reintubation, ventilator use for more than 48 h, infection of the urinary tract, renal insufficiency, acute renal failure, deep-vein thrombosis or thrombophlebitis, cardiac arrest, cerebrovascular incident or stroke, myocardial infarction, sepsis, and septic shock), we focused on those for which at least one case was reported. Detailed information on postoperative outcomes after head and neck OSA surgery is listed in Table 4, Table 5 and Table 6.
Of note, as the primary composite outcome, we defined the occurrence of any complication, i.e., mortality, reoperation, readmission, unplanned readmission, any surgical complication, or any medical complication. In this context, it is important to mention that we counted the total number of patient cases and not the sheer number of complications. In other words, if a patient both returned to the operating room and experienced a medical complication, this was recorded as any complication n = 1. Second, we analyzed all individual outcomes separately and determined the mean length of hospital stay. To this end, we evaluated the frequency of mortality, reoperation, (unplanned) readmission, any surgical, and any medical complication. The latter two included the occurrence of superficial or deep incisional infection, organ-space infection, dehiscence, pneumonia, reintubation, pulmonary embolism, ventilator use for more than 48 h, myocardial infarction, cardiac arrest, deep-vein thrombosis or thrombophlebitis, urinary tract infection, sepsis, and septic shock.
2.3. Statistical Analysis
Data were collected and stored in an electronic laboratory notebook (LabArchives, LLC, San Marcos, CA, USA) and evaluated with GraphPad Prism (V9.00 for MacOS, GraphPad Software, La Jolla, CA, USA). Continuous variables (i.e., age and BMI) were analyzed with independent t-tests and reported as means with standard deviations. Pearson’s chi-squared test was used to measure differences in categorical variables. In cases with fewer than 10 events, Fisher’s exact test was applied. Statistical significance was measured at p < 0.05. a univariable subgroup analysis was performed to accomplish risk-associated factors for complications by separating the cohort into three groups depending on the occurrence of any, surgical, or medical complications. An in-depth statistical analysis was conducted using ordinary least squares (OLS) based on a multivariate logistic regression analysis. OLS regression is a statistical-mathematical method calculating the association between one or more independent variables and a dependent variable. Multivariate regression is considered an advanced version of normal OLS regression. These models were performed to control for confounding by including all variables found to be significant risk-associated factors for the occurrence of any, surgical, or medical complications. More specifically, this analysis was adjusted for gender, BMI, setting, diabetes, hypertension, and ASA physical status classification (any complications); for age, race, setting, COPD, and dyspnea (surgical complications); and for BMI, setting, diabetes, obesity, corticosteroid use, ASA physical status classification, and functional status (medical complications).
3. Results
3.1. Patient Demographics
The study population included 4662 patients who underwent OSA surgery over a 13-year review period (2008–2020). The average patient age was 42 ± 13, while male (n = 3388; 73%) and white (n = 2979; 64) patients with class-1 or -2 obesity (BMI: 33 ± 7.7) accounted for the majority of OSA surgery candidates. Obesity (n = 2909; 63%) and hypertension (n = 1435; 31%) were the most frequent comorbidities. In our study population, 16% (n = 742) declared to be current smokers. Detailed demographic data and comorbidities of the entire study population are described in Table 1. Supplementary Table S1 focuses on patients who underwent isolated uvulopalatopharyngoplasty, palatopharyngoplasty, and tonsillectomy procedures and provides a breakdown of their characteristics.
3.2. Surgical Characteristics
Isolated palatopharyngoplasty (PPP) (n = 1161; 25%) was the most frequently performed surgery, with tonsillectomy (PPP with tonsillectomy) (n = 887; 19%) and turbinate reduction (PPP with turbinate reduction) (n = 409; 8.8%) as most common multilevel procedures. Most procedures were performed in an outpatient setting (n = 3280; 70%). Table 2 and Table 3 display surgical characteristics in detail.
3.3. Perioperative Outcomes
The mean operation time was 66 ± 54 min. After a postoperative LOS of 0.9 ± 2.0 days on average, 84% (n = 3956) of patients were discharged home (Table 4).
3.4. Postoperative Surgical and Medical Outcomes
The occurrence of any complication (i.e., mortality, reoperation, readmission, unplanned readmission, any surgical complication, or any medical complication) was recorded in 292 patient cases (6.3%) (Table 4). While two (0.04%) deaths were reported within the 30-day postoperative period, the reoperation rate amounted to 3.5% (n = 163). The surgical complication rate was 1.0% (n = 48), with superficial incisional infection (n = 26; 0.6%) as the most frequently reported adverse surgical event. Medical complications occurred in 55 (1.2%) cases, of which pneumonia constituted 21 (0.5%) cases. Male sex (p = 0.03), increased BMI (p = 0.01), inpatient setting (p < 0.0001), history of diabetes (p = 0.002), hypertension requiring treatment (p = 0.03), and ASA scores ≥ 4 (p < 0.0001) were identified as risk-associated factors for the occurrence of any postoperative complications. Advanced age (p = 0.04), inpatient setting (p = 0.0002), history of COPD (p = 0.003), and dyspnea (p = 0.03) were identified as risk-associated factors for the occurrence of any surgical complication. In terms of medical complications, increased BMI (p < 0.0001), inpatient setting (p < 0.0001), history of diabetes (p < 0.0001), corticosteroid use (p = 0.01), and ASA scores ≥ 4 (p = 0.0006) were identified as risk-associated factors. A multivariable analysis confirmed that ASA score and diabetes were independent risk-associated factors for the occurrence of any complication (p = 0.03 and p = 0.001, respectively; Table 7). Further details about the multivariable assessments of any, surgical, and medical complications are described in Table 7 and Table 8. Increased alkaline phosphatase (ALP) was identified as a risk-associated factor for the occurrence of any complication (p = 0.02) and medical complications (p = 0.001). Detailed preoperative lab value data are described in Table 9.
To delineate a correlation pattern between the type of procedure performed and the occurrence of adverse events, we first reviewed the total number of complications. We found that most complications occurred in patients who underwent palatopharynoplasty (PPP), (n = 65) followed by patients receiving tonsillectomy (n = 50) (Table 5). This was not surprising considering that these two surgical procedures also numerically accounted for the largest proportion of the cohort (Figure 1). We, therefore, calculated a complication rate (defined as the number of complications within a surgery type relative to the total number of patients who underwent that specific procedure; Table 5). A comparison of complication rates among the different (sub)types of surgery revealed that there were no statistically significant differences between isolated procedures and multilevel surgeries (Supplementary Table S2). When focusing exclusively on isolated procedures, we found isolated tonsillectomy to be associated with a significantly higher risk than isolated uvulopalatopharyngoplasty (p = 0.009) and isolated palatopharyngoplasty (p = 0.02; Supplementary Table S3). Further, tracheostomy showed significantly higher complication rates than isolated uvulopalatopharyngoplasty (p = 0.009), isolated palatopharyngoplasty (p = 0.02), and isolated uvulectomy (p = 0.01; Figure 2 and Supplementary Table S3). Comparable trends were also noticeable in the multivariable assessment of complication occurrences among the different (sub)types of surgery. While isolated tonsillectomy was found to be statistically significantly associated with any complications (p = 0.003), tracheostomy surgery was associated with significantly higher risks for any (p = 0.04) and medical complications (p = 0.04; Table 8). The multivariable analysis suggested two surgical combinations as high-risk conditions for the occurrence of postoperative complications. Namely, combined genioglossus advancement and maxillomandibular advancement, as well as combined palatopharyngoplasty and tonsillectomy, were frequent among the risk-associated types of surgery (Table 8).
4. Discussion
Big databases represent a powerful tool for tracking surgical outcomes and improving patient care. For OSA patients, as a vulnerable patient group per se, it is important for surgeons to thoroughly determine a patient’s risk profile prior to undergoing surgery [12]. We queried the ACS-NSQIP database to investigate medical and surgical complications and risk-associated factors, as well as 30-day postoperative outcomes, in 4662 OSA surgery cases.
For the purpose of a homogeneous patient cohort (and, thus, for better interindividual comparability), we excluded all cases of bariatric surgery as a therapeutic approach for OSA. Nonetheless, in our study population undergoing head and neck surgery, middle-aged (42 ± 13 years of age) males with class-1 obesity (BMI: 33 ± 7.3 kg/m2) still represented the most common OSA patient. This finding aligns with recent studies by Du et al. and Zaghi et al. who each investigated demographic patterns in OSA surgery [13,14]. Further, we found that 62% of patients undergoing upper airway surgery suffered from obesity and 31% from hypertension, while 16% of patients were current smokers. The high prevalence of comorbidities, such as obesity, was also reported in a 2014 Korean population study of 348 patients, as well as in a 2015 study by Heinzer et al. including 2121 OSA patients [15,16]. The high prevalence of nicotine abuse in OSA patients has also been described in the scientific literature [17,18]. Our findings, therefore, underscore the vulnerability of this specific patient group (i.e., middle-aged, male, and obese patients with a medical record of nicotine abuse) to OSA. With the background of increasing worldwide obesity rates and persistently high smoking prevalence, joint efforts are needed to sensitize and target risk patients, such as overweight adolescents or current smokers, before the clinical manifestation of OSA symptoms [19,20,21].
Surgical OSA therapy is a case-to-case decision based upon individual anatomical findings with the possible combination of different surgical techniques in multilevel surgeries [2,22]. Of note, UPPP, which was considered the standard OSA surgery prior, has been successively replaced by multilevel surgery to simultaneously address variables that predispose patients to UPPP-resistant OSA (e.g., narrowing or collapse at sites other than the retropalate) [23]. The multilevel approach renders perioperative risk evaluation more challenging and necessitates procedure-adjusted complication assessment. In our study, isolated UPPP accounted for 6.9% of the cases, while palatopharyngoplasty combined with different concurrent procedures accounted for 40% of the patients (Figure 1). This distribution pattern corroborates the ongoing shift toward concomitant surgeries in OSA patients.
Regarding complication rates, different studies have shown overall perioperative complication rates in OSA surgery ranging between 1.0% and 15% [22,24]. More recent reports have indicated relatively low complication rates for OSA surgery: while van Daele et al. documented reoperation rates and surgical site infections in 4.8% and 0.9% of all cases, respectively, Rosero et al. found postoperative complications occurring in 6.4% of surgical OSA patients [25,26]. Both authors reported surgery-related mortality rates of less than 0.1%. Overall, these numbers are comparable to our analysis, where we found 2 cases of death (0.4%), 292 (6.3%) cases of any complications, and 163 reoperations (3.5%) due to complications.
Interestingly, in our study, no significant differences in the occurrences of complications and the incidences of readmissions and reoperations were found between multilevel surgeries and isolated procedures (Supplementary Table S2). The stacking of concomitant procedures for customized patient therapy was not associated with a significantly increased risk. This finding is in line with recent studies that have highlighted the safety profile of multilevel OSA surgery [27,28,29,30,31]. More specifically, the SAMS randomized clinical trial involved 51 patients undergoing multilevel OSA surgery (i.e., uvulopalatopharyngoplasty and minimally invasive tongue volume reduction), with only two participants (4%) experiencing postoperative adverse events [30]. Similarly, Bosco et al. reported the absence of any unexpected complications during the postoperative follow-up of 24 patients receiving one-stage multilevel OSA surgery (pharyngoplasty, tongue base reduction, or partial epiglottectomy) [31]. In 2021, a meta-analysis evaluated 37 studies and a total of 1639 patients undergoing multilevel OSA surgery. With major complications being reported in only 1.1% of all cases, this analysis further validated the procedures’ safety [29]. Thus, our study substantiates the current trend towards multilevel OSA surgery also from a risk-associated standpoint. However, we identified two surgical combinations (i) genioglossus advancement plus concomitant maxillomandibular advancement and ii) palatopharyngoplasty plus parallel tonsillectomy) as high-risk procedures. Therefore, although this study may encourage surgeons to consider concomitant procedures for more tailored surgical management of OSA patients, surgeons should pay particular attention to these two combinations during preoperative planning and critically evaluate patients’ eligibility. In this context, we advocate an individualized case-by-case decision that takes into account both the patient characteristics and the relevant circumstances (such as psychosocial support, monetary burden, and available (mid- and long-term) nursing). The proposed predictive factors, including patient gender, body weight, comorbidities, and laboratory values, may aid in achieving an evidence-based risk assessment.
Of note, tracheostomy was also identified as a risk-associated factor for both any and medical complications, regardless of the main surgical procedure. In general, tracheostomy has been shown to be a safe airway management technique in most cases, as well as a potential, yet uncommon, therapeutic alternative for patients with severe OSA [32,33,34,35,36]. Still, tracheostomy is an invasive procedure that carries a risk of high morbidity. The spectrum of potential adverse events is broad, ranging from postoperative bleeding and infection to tracheal wall injury and tube obstruction. Further tracheostomy-related complications (such as stenosis, malacia, and fistula formation) may also be life-threatening by affecting airway passability, ultimately rendering this procedure one of the most morbid in the wide field of OSA therapy [37,38,39]. Koitschev et al. showed that the surgical technique used for tracheotomy influenced the risk for tracheostomy-related complications. They found that surgical approaches resulting in an epithelialized tracheostoma minimized the risk for tracheostomy-related complications [40]. To our knowledge, this is the first study to outline the increased risk of tracheostomy in OSA surgery. Therefore, surgeons may critically weigh the potential benefits of tracheostomy, such as enhanced nursing care, against the additional complication risk in OSA patients. However, this finding should be corroborated on larger scales.
OSA patients represent a vulnerable patient group in surgical risk management [12,41]. Therefore, the identification of risk-associated factors plays a pivotal role in enhancing patient care. In our analysis, we found male gender, diabetes mellitus, and ASA scores ≥ 4 to be predictive of any complications. While these factors have been described as risk-associated factors in other fields of surgery, this is the first study to reveal an increased risk for this patient profile when undergoing OSA surgery [42,43,44,45,46,47,48]. For medical complications, we not only found extreme obesity (i.e., BMI > 40 kg/m2) but also underweight status (i.e., BMI < 18.5 kg/m2) to be significant risk-associated factors (Table 7; Supplementary Figure S1). While Du et al. found the same for OSA surgery patients in obesity classes 2 and 3 when analyzing 1923 OSA surgery cases, this is the first study to reveal an increased risk of medical complications in underweight patients who underwent OSA surgery. Further, we identified elevated alkaline phosphatase (ALP) values to be predictive of medical and surgical complications following OSA surgery. Increased ALP levels can be due to hepatic and biliary diseases, as well as bone disorders [49,50]. Increased ALP values have been implicated with elevated complication rates in other types of surgery, but the exact pathomechanism by which ALP influences perioperative patient health remains to be determined [51,52]. Based on our analysis, we propose that particular attention be paid to patients with ALP levels lower than 81.5 U/L given the association with postoperative complications.
Although the experience, dexterity, and expertise of the surgeon can have a substantial impact on therapeutic success, a series of pre- and perioperative measures can help optimize patient safety. Care providers may, therefore, wish to implement the identified risk-associated factors into their clinical workflow to optimize (i) patient counseling, (ii) high-risk patient group identification, (iii) preoperative patient-tailored planning, (iv) perioperative multimodal monitoring, and (v) postoperative (long-term) follow-up. Thus, by updating and upgrading the risk assessment armamentarium, an individual surgeon can contribute to further honing surgical OSA management.
Limitations
To the best of our knowledge, the study is the first to analyze risks, complications, and outcomes after different kinds of surgical treatment in OSA patients based on multi-center data collected over more than a decade. However, interpretation of the findings considering the study’s limitations is mandatory. First, we would like to emphasize that we analyzed correlations and not causalities with the statistical calculations. We identified factors that were associated with higher perioperative risk. However, the underlying causal mechanisms remain to be elucidated. In general, the NSQIP database only provides a limited postoperative follow-up for a 30-day period, meaning that long-term complications, e.g., disease recurrence, remain uncovered [53]. Further, this study entails the risk of unconsidered bias and confounding factors due to its conceptualization as a retrospective data analysis. Due to subjectivity and the unequal expertise of professional database documentation, intra- and interinstitutional differences in the precision and completeness of data collection represent additional limitations in data comparison [54]. However, the robustness, quality, and validity of the entered information are warranted by spot audits and peer controls [55,56]. In fact, according to Shiloach et al., the NSQIP database established low variance in heterogeneity by means of trained data collectors and ongoing audits of data reliability [57].
The range of OSA therapy is far-reaching. The ACS-NSQIP does not cover all of the available treatment modalities [25]. As such, e.g., the implantation and use of a hypoglossal nerve stimulator device (“upper airway stimulation system”) is not included in this study. Protocols and therapeutic approaches in the surgical management of OSA vary across the globe [58,59,60,61]. Since the NSQIP is a national US database, the transferability of our findings is limited to the American healthcare system [62]. Lacking information about significant subgroup variables, including OSA severity and primary OSA treatment, may lead to deviating outcomes in patient cases. Not considering the initial severity of OSA and the corresponding degree of invasiveness of the surgical procedure, complication rates constitute a kind of average value without the possibility of exact procedure identification. The NSQIP database does not provide information regarding the improvement of OSA symptoms after surgery; thus, no conclusions regarding the impact of risk-associated factors on surgical success rates could be drawn. Furthermore, the ACS-NSQIP database does not specify the criteria upon which an OSA diagnosis is generated and validated. Thus, it cannot be ascertained whether overnight polysomnography was used as a diagnostic procedure. Nevertheless, despite the aforementioned limitations, we are convinced of the study’s significance, validity, and value. The described findings may help further refine the perioperative protocols of OSA surgery and, ultimately, optimize patient care.
5. Conclusions
Utilizing the NSQIP-ACS big database, we analyzed 4662 patients undergoing OSA surgery over a 13-year period. We identified that elevated ALP levels (≥81.5 U/L), male gender, diabetes mellitus, values at extreme ends of the BMI scale (BMI < 18.5 kg/m2 and >40 kg/m2), and ASA scores ≥ 4 were predictive factors for postoperative complications. Awareness of these risk-associated factors may help surgeons carefully balance a patient’s eligibility and refine their perioperative management. More specifically, by accounting for these factors during the preoperative planning stage, high-risk patients can be preemptively identified and closely monitored. Moreover, we noted no significant differences in the safety profiles between multilevel surgeries and isolated interventions. While these findings generally imply a step toward treatment individualization, we revealed two (relatively) high-risk surgical combinations (i.e., genioglossus advancement plus concomitant maxillomandibular advancement and palatopharyngoplasty plus parallel tonsillectomy). In addition, cases involving tracheostomy were found to be associated with an increased incidence of adverse events. OSA surgeons should be mindful of these correlations when planning individual treatments and counseling patients.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jcm11247371/s1. Table S1: Demographics and comorbidities of all patients who underwent isolated uvulopalatopharyngoplasty (UPPP), palatopharyngoplasty (PPP), and tonsillectomy. Table S2: Comparison of complication rates in the different procedures when the procedures were performed as isolated procedures and when they were performed in combination with other procedures. Table S3: Comparison of complication rates in the different procedures when the procedures were performed as isolated procedures. Figure S1: Frequency of complications stratified by BMI classes.
Author Contributions
Conceptualization, S.K., L.K. and A.C.P.; Methodology, S.K., L.K., H.B. and A.C.P.; Formal analysis, S.K., L.K., M.K.-N. and A.C.P.; Investigation, S.K. and L.K.; Data curation, M.K.-N.; Writing—original draft, S.K., L.K. and A.C.P.; Writing—review & editing, H.B., M.K.-N., D.O., C.C.H., Y.F.D., P.S.V., U.H., U.K. and A.C.P.; Visualization, D.O., C.C.H. and A.C.P.; Supervision, U.K. and A.C.P.; Project administration, M.K-N. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Informed Consent Statement
Not applicable.
Data Availability Statement
Restrictions apply to the availability of these data. Data were obtained from the American College of Surgeons—National Surgical Quality Improvement Program. The application can be submitted at https://accreditation.facs.org/programs/nsqip.
Conflicts of Interest
None of the authors have financial interest in any of the products, devices, or drugs mentioned in this manuscript.
References
- Epstein, L.J.; Kristo, D.; Strollo, P.J., Jr.; Friedman, N.; Malhotra, A.; Patil, S.P.; Ramar, K.; Rogers, R.; Schwab, R.J.; Weaver, E.M.; et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep Med. 2009, 5, 263–276. [Google Scholar]
- Jordan, A.S.; White, D.P. Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir. Physiol. Neurobiol. 2008, 160, 1–7. [Google Scholar] [CrossRef] [Green Version]
- Gottlieb, D.J.; Punjabi, N.M. Diagnosis and Management of Obstructive Sleep Apnea: A Review. JAMA 2020, 323, 1389–1400. [Google Scholar] [CrossRef]
- Mehra, R. Sleep apnea and the heart. Cleve Clin. J. Med. 2019, 86, 10–18. [Google Scholar] [CrossRef]
- Sabil, A.; Bignard, R.; Gerves-Pinquie, C.; Philip, P.; Le Vaillant, M.; Trzepizur, W.; Meslier, N.; Gagnadoux, F. Risk Factors for Sleepiness at the Wheel and Sleep-Related Car Accidents Among Patients with Obstructive Sleep Apnea: Data from the French Pays de la Loire Sleep Cohort. Nat. Sci. Sleep 2021, 13, 1737–1746. [Google Scholar] [CrossRef]
- Hirsch Allen, A.J.M.; Bansback, N.; Ayas, N.T. The effect of OSA on work disability and work-related injuries. Chest 2015, 147, 1422–1428. [Google Scholar] [CrossRef]
- Patil, S.P.; Ayappa, I.A.; Caples, S.M.; Kimoff, R.J.; Patel, S.R.; Harrod, C.G. Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment. J. Clin. Sleep Med. 2019, 15, 301–334. [Google Scholar] [CrossRef]
- Kezirian, E.J.; Maselli, J.; Vittinghoff, E.; Goldberg, A.N.; Auerbach, A.D. Obstructive sleep apnea surgery practice patterns in the United States: 2000 to 2006. Otolaryngol. Head Neck Surg. 2010, 143, 441–447. [Google Scholar] [CrossRef] [Green Version]
- Liao, P.; Yegneswaran, B.; Vairavanathan, S.; Zilberman, P.; Chung, F. Postoperative complications in patients with obstructive sleep apnea: A retrospective matched cohort study. Can. J. Anesth./J. Can. D’anesthésie 2009, 56, 819. [Google Scholar] [CrossRef]
- Kezirian, E.J.; Weaver, E.M.; Yueh, B.; Deyo, R.A.; Khuri, S.F.; Daley, J.; Henderson, W. Incidence of serious complications after uvulopalatopharyngoplasty. Laryngoscope 2004, 114, 450–453. [Google Scholar] [CrossRef] [Green Version]
- Practice guidelines for the perioperative management of patients with obstructive sleep apnea: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2014, 120, 268–286. [CrossRef]
- Kaw, R.; Pasupuleti, V.; Walker, E.; Ramaswamy, A.; Foldvary-Schafer, N. Postoperative complications in patients with obstructive sleep apnea. Chest 2012, 141, 436–441. [Google Scholar] [CrossRef] [Green Version]
- Zaghi, S.; Holty, J.E.; Certal, V.; Abdullatif, J.; Guilleminault, C.; Powell, N.B.; Riley, R.W.; Camacho, M. Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea: A Meta-analysis. JAMA Otolaryngol. Head Neck Surg. 2016, 142, 58–66. [Google Scholar] [CrossRef]
- Du, A.L.; Tully, J.L.; Curran, B.P.; Gabriel, R.A. Obesity and outcomes in patients undergoing upper airway surgery for obstructive sleep apnea. PLoS ONE 2022, 17, e0272331. [Google Scholar] [CrossRef]
- Heinzer, R.; Vat, S.; Marques-Vidal, P.; Marti-Soler, H.; Andries, D.; Tobback, N.; Mooser, V.; Preisig, M.; Malhotra, A.; Waeber, G.; et al. Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respir. Med. 2015, 3, 310–318. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.D.; Kang, S.H.; Ju, G.; Han, J.W.; Kim, T.H.; Lee, C.S.; Kim, T.; Kim, K.W.; Yoon, I.Y. The prevalence of and risk factors for sleep-disordered breathing in an elderly Korean population. Respiration 2014, 87, 372–378. [Google Scholar] [CrossRef]
- Bednarek, M.; Plywaczewski, R.; Jonczak, L.; Zielinski, J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: A population study. Respiration 2005, 72, 142–149. [Google Scholar] [CrossRef]
- Choi, K.M.; Thomas, R.J.; Kim, J.; Lee, S.K.; Yoon, D.W.; Shin, C. Overlap syndrome of COPD and OSA in Koreans. Medicine 2017, 96, e7241. [Google Scholar] [CrossRef]
- Reitsma, M.B.; Kendrick, P.J.; Ababneh, E.; Abbafati, C.; Abbasi-Kangevari, M.; Abdoli, A.; Abedi, A.; Abhilash, E.S.; Abila, D.B.; Aboyans, V.; et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet 2021, 397, 2337–2360. [Google Scholar] [CrossRef]
- Chooi, Y.C.; Ding, C.; Magkos, F. The epidemiology of obesity. Metabolism 2019, 92, 6–10. [Google Scholar] [CrossRef] [Green Version]
- Islami, F.; Torre, L.A.; Jemal, A. Global trends of lung cancer mortality and smoking prevalence. Transl. Lung Cancer Res. 2015, 4, 327–338. [Google Scholar] [CrossRef]
- Lin, H.C.; Weaver, E.M.; Lin, H.S.; Friedman, M. Multilevel Obstructive Sleep Apnea Surgery. Adv. Otorhinolaryngol. 2017, 80, 109–115. [Google Scholar] [CrossRef]
- Friedman, J.J.; Salapatas, A.M.; Bonzelaar, L.B.; Hwang, M.S.; Friedman, M. Changing Rates of Morbidity and Mortality in Obstructive Sleep Apnea Surgery. Otolaryngol. Head Neck Surg. 2017, 157, 123–127. [Google Scholar] [CrossRef]
- Barrera, J.E. Skeletal Surgery for Obstructive Sleep Apnea. Otolaryngol. Clin. N. Am. 2016, 49, 1433–1447. [Google Scholar] [CrossRef]
- Van Daele, D.J.; Cromwell, J.W.; Hsia, J.K.; Nord, R.S. Post-operative Complication Rate Comparison Between Airway Surgery and Upper Airway Stimulation Using NSQIP and ADHERE. OTO Open 2021, 5, 2473974X211051313. [Google Scholar] [CrossRef]
- Rosero, E.B.; Joshi, G.P. Outcomes of Sleep Apnea Surgery in Outpatient and Inpatient Settings. Anesth. Analg. 2021, 132, 1215–1222. [Google Scholar] [CrossRef]
- Saenwandee, P.; Neruntarat, C.; Saengthong, P.; Wiriyaamornchai, P.; Khuancharee, K.; Sirisomboonwech, S.; Chuoykwamdee, N. Barbed pharyngoplasty for obstructive sleep apnea: A meta-analysis. Am. J. Otolaryngol. 2022, 43, 103306. [Google Scholar] [CrossRef]
- Gafar, H.A.-L.; Abdulla, A.E.-D.A.; Ghanem, Y.Y.; Bahgat, A.Y. Comparative study between single-stage multilevel surgery and staged surgery for management of snoring and/or obstructive sleep apnea. Egypt. J. Otolaryngol. 2022, 38, 90. [Google Scholar] [CrossRef]
- Zhou, N.; Ho, J.T.F.; Huang, Z.; Spijker, R.; de Vries, N.; Aarab, G.; Lobbezoo, F.; Ravesloot, M.J.L.; de Lange, J. Maxillomandibular advancement versus multilevel surgery for treatment of obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med. Rev. 2021, 57, 101471. [Google Scholar] [CrossRef]
- MacKay, S.; Carney, A.S.; Catcheside, P.G.; Chai-Coetzer, C.L.; Chia, M.; Cistulli, P.A.; Hodge, J.-C.; Jones, A.; Kaambwa, B.; Lewis, R.; et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA 2020, 324, 1168–1179. [Google Scholar] [CrossRef]
- Bosco, G.; Morato, M.; Pérez-Martín, N.; Navarro, A.; Racionero, M.A.; O’Connor-Reina, C.; Baptista, P.; Plaza, G. One-Stage Multilevel Surgery for Treatment of Obstructive Sleep Apnea Syndrome. J. Clin. Med. 2021, 10, 4822. [Google Scholar] [CrossRef] [PubMed]
- Browaldh, N.; Markström, A.; Friberg, D. Elective tracheostomy is an alternative treatment in patients with severe obstructive sleep apnoea syndrome and CPAP failure. Acta Otolaryngol. 2009, 129, 1121–1126. [Google Scholar] [CrossRef] [Green Version]
- Camacho, M.; Zaghi, S.; Chang, E.T.; Song, S.A.; Szelestey, B.; Certal, V. Mini Tracheostomy for Obstructive Sleep Apnea: An Evidence Based Proposal. Int. J. Otolaryngol. 2016, 2016, 7195349. [Google Scholar] [CrossRef] [Green Version]
- Rizzi, C.J.; Amin, J.D.; Isaiah, A.; Valdez, T.A.; Jeyakumar, A.; Smart, S.E.; Pereira, K.D. Tracheostomy for Severe Pediatric Obstructive Sleep Apnea: Indications and Outcomes. Otolaryngol. Head Neck Surg. 2017, 157, 309–313. [Google Scholar] [CrossRef]
- Camacho, M.; Certal, V.; Brietzke, S.E.; Holty, J.E.; Guilleminault, C.; Capasso, R. Tracheostomy as treatment for adult obstructive sleep apnea: A systematic review and meta-analysis. Laryngoscope 2014, 124, 803–811. [Google Scholar] [CrossRef]
- Thatcher, G.W.; Maisel, R.H. The long-term evaluation of tracheostomy in the management of severe obstructive sleep apnea. Laryngoscope 2003, 113, 201–204. [Google Scholar] [CrossRef]
- Fernandez-Bussy, S.; Mahajan, B.; Folch, E.; Caviedes, I.; Guerrero, J.; Majid, A. Tracheostomy Tube Placement: Early and Late Complications. J. Bronchol. Interv. Pulmonol. 2015, 22, 357–364. [Google Scholar] [CrossRef]
- Rosero, E.B.; Corbett, J.; Mau, T.; Joshi, G.P. Intraoperative Airway Management Considerations for Adult Patients Presenting With Tracheostomy: A Narrative Review. Anesth. Analg. 2021, 132, 1003–1011. [Google Scholar] [CrossRef]
- Cipriano, A.; Mao, M.L.; Hon, H.H.; Vazquez, D.; Stawicki, S.P.; Sharpe, R.P.; Evans, D.C. An overview of complications associated with open and percutaneous tracheostomy procedures. Int. J. Crit. Illn. Inj. Sci. 2015, 5, 179–188. [Google Scholar] [CrossRef] [Green Version]
- Koitschev, A.; Simon, C.; Blumenstock, G.; Mach, H.; Graumueller, S. Surgical technique affects the risk for tracheostoma-related complications in post-ICU patients. Acta Otolaryngol. 2006, 126, 1303–1308. [Google Scholar] [CrossRef]
- Kaw, R.; Gali, B.; Collop, N.A. Perioperative care of patients with obstructive sleep apnea. Curr. Treat. Options Neurol. 2011, 13, 496–507. [Google Scholar] [CrossRef] [PubMed]
- Bamba, R.; Gupta, V.; Shack, R.B.; Grotting, J.C.; Higdon, K.K. Evaluation of Diabetes Mellitus as a Risk Factor for Major Complications in Patients Undergoing Aesthetic Surgery. Aesthet. Surg. J. 2016, 36, 598–608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dulai, M.; Tawfick, W.; Hynes, N.; Sultan, S. Female Gender as a Risk Factor for Adverse Outcomes After Carotid Revascularization. Ann. Vasc. Surg. 2019, 60, 254–263. [Google Scholar] [CrossRef] [PubMed]
- Fitz-Henry, J. The ASA classification and peri-operative risk. Ann. R. Coll. Surg. Engl. 2011, 93, 185–187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Negus, O.J.; Watts, D.; Loveday, D.T. Diabetes: A major risk factor in trauma and orthopaedic surgery. Br. J. Hosp. Med. 2021, 82, 1–5. [Google Scholar] [CrossRef]
- Hackett, N.J.; De Oliveira, G.S.; Jain, U.K.; Kim, J.Y. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int. J. Surg. 2015, 18, 184–190. [Google Scholar] [CrossRef]
- Davenport, D.L.; Bowe, E.A.; Henderson, W.G.; Khuri, S.F.; Mentzer, R.M., Jr. National Surgical Quality Improvement Program (NSQIP) risk factors can be used to validate American Society of Anesthesiologists Physical Status Classification (ASA PS) levels. Ann. Surg. 2006, 243, 636–641, discussion 641–634. [Google Scholar] [CrossRef]
- Kandasamy, T.; Wright, E.D.; Fuller, J.; Rotenberg, B.W. The incidence of early post-operative complications following uvulopalatopharyngoplasty: Identification of predictive risk factors. J. Otolaryngol. Head Neck Surg. 2013, 42, 15. [Google Scholar] [CrossRef] [Green Version]
- Maldonado, O.; Demasi, R.; Maldonado, Y.; Taylor, M.; Troncale, F.; Vender, R. Extremely high levels of alkaline phosphatase in hospitalized patients. J. Clin. Gastroenterol. 1998, 27, 342–345. [Google Scholar] [CrossRef]
- Moss, D.W. Alkaline phosphatase isoenzymes. Clin. Chem. 1982, 28, 2007–2016. [Google Scholar] [CrossRef]
- Karhade, A.V.; Thio, Q.; Ogink, P.T.; Schwab, J.H. Serum alkaline phosphatase and 30-day mortality after surgery for spinal metastatic disease. J. Neurooncol. 2018, 140, 165–171. [Google Scholar] [CrossRef] [PubMed]
- Kudsk, K.A.; Tolley, E.A.; DeWitt, R.C.; Janu, P.G.; Blackwell, A.P.; Yeary, S.; King, B.K. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J. Parenter. Enter. Nutr. 2003, 27, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Panayi, A.C.; Haug, V.; Kauke-Navarro, M.; Foroutanjazi, S.; Diehm, Y.F.; Pomahac, B. The modified 5-item frailty index is a predictor of perioperative risk in head and neck microvascular reconstruction: An analysis of 3795 cases. Am. J. Otolaryngol. 2021, 42, 103121. [Google Scholar] [CrossRef] [PubMed]
- Nørgaard, M.; Ehrenstein, V.; Vandenbroucke, J.P. Confounding in observational studies based on large health care databases: Problems and potential solutions—A primer for the clinician. Clin. Epidemiol. 2017, 9, 185–193. [Google Scholar] [CrossRef] [Green Version]
- American College of Surgeons. Quality Programs. Frequently Asked Questions. Available online: https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/faq/ (accessed on 18 November 2022).
- American College of Surgeons. User Guide for the 2016 ACS NSQIP Participant Use Data File (PUF). Available online: https://www.facs.org/media/kthpmx3h/nsqip_puf_userguide_2016.pdf (accessed on 18 November 2022).
- Shiloach, M.; Frencher, S.K., Jr.; Steeger, J.E.; Rowell, K.S.; Bartzokis, K.; Tomeh, M.G.; Richards, K.E.; Ko, C.Y.; Hall, B.L. Toward robust information: Data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J. Am. Coll. Surg. 2010, 210, 6–16. [Google Scholar] [CrossRef]
- MacKay, S.G.; Lewis, R.; McEvoy, D.; Joosten, S.; Holt, N.R. Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association. Respirology 2020, 25, 1292–1308. [Google Scholar] [CrossRef]
- Tan, J.W.C.; Leow, L.C.; Wong, S.; Khoo, S.M.; Kasai, T.; Kojodjojo, P.; Sy, D.Q.; Lee, C.P.; Chirakalwasan, N.; Li, H.Y.; et al. Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease. Eur. Cardiol. 2022, 17, e16. [Google Scholar] [CrossRef]
- Rösslein, M.; Bürkle, H.; Walther, A.; Stuck, B.A.; Verse, T. Positionspapier zum perioperativen Management von erwachsenen Patienten mit obstruktiver Schlafapnoe bei HNO-ärztlichen Eingriffen. [Position Paper: Perioperative Management of Adult Patients with Obstructive Sleep Apnea in ENT Surgery]. Laryngorhinootologie 2015, 94, 516–523. [Google Scholar] [CrossRef]
- Chang, J.L.; Goldberg, A.N.; Alt, J.A.; Ashbrook, L.; Auckley, D.; Ayappa, I.; Bakhtiar, H.; Barrera, J.E.; Bartley, B.L.; Billings, M.E.; et al. International consensus statement on obstructive sleep apnea. Int. Forum Allergy Rhinol. 2022. [Google Scholar] [CrossRef]
- Haug, V.; Kadakia, N.; Wang, A.T.; Dorante, M.I.; Panayi, A.C.; Kauke-Navarro, M.; Hundeshagen, G.; Diehm, Y.F.; Fischer, S.; Hirche, C.; et al. Racial disparities in short-term outcomes after breast reduction surgery-A National Surgical Quality Improvement Project Analysis with 23,268 patients using Propensity Score Matching. J. Plast Reconstr. Aesthet. Surg. 2022, 75, 1849–1857. [Google Scholar] [CrossRef]
Figure 1.
Procedure distribution. Procedures performed concomitantly with other procedures (combined procedures) are shown with a striped pattern. The majority of procedures (>65%) were PPPs, followed by tonsillectomies. The exact numbers are shown in Table 3. PPP, palatopharyngoplasty; UPPP, uvulopalatopharyngoplasty.
Figure 1.
Procedure distribution. Procedures performed concomitantly with other procedures (combined procedures) are shown with a striped pattern. The majority of procedures (>65%) were PPPs, followed by tonsillectomies. The exact numbers are shown in Table 3. PPP, palatopharyngoplasty; UPPP, uvulopalatopharyngoplasty.
Figure 2.
Complications rates for different procedures. Isolated and combined procedures did not significantly differ in terms of complication rates. Tonsillectomy, when performed as an isolated procedure, had a significantly higher rate of complications than isolated UPPP or isolated PPP. Tracheostomy procedures had the highest rate of complications, significantly higher than isolated UPPP, isolated PPP, and isolated uvulectomy. The exact numbers are shown in Supplementary Tables S2 and S3.
Figure 2.
Complications rates for different procedures. Isolated and combined procedures did not significantly differ in terms of complication rates. Tonsillectomy, when performed as an isolated procedure, had a significantly higher rate of complications than isolated UPPP or isolated PPP. Tracheostomy procedures had the highest rate of complications, significantly higher than isolated UPPP, isolated PPP, and isolated uvulectomy. The exact numbers are shown in Supplementary Tables S2 and S3.
Table 1.
Patient demographics and comorbidities. Reported as n (%), unless otherwise stated.
| Characteristic | Patients (n = 4662) |
|---|---|
| Demographics | |
| Sex | |
| Female (n) | 1273 (27) |
| Male (n) | 3388 (73) |
| Age, mean ± SD | 42 ± 13 |
| BMI, mean ± SD | 33 ± 7.3 |
| Race | |
| American Indian or Alaskan Native | 28 (0.6) |
| Asian | 244 (5.2) |
| Native Hawaiian or Pacific Islander | 51 (1.1) |
| Black or African American | 544 (12) |
| White | 2979 (64) |
| Other or unknown | 804 (17) |
| Preoperative health and comorbidities | |
| Diabetes | 469 (10) |
| Insulin-treated diabetes | 137 (2.9) |
| COPD | 60 (1.3) |
| CHF | 5 (0.1) |
| Obesity | 2909 (62) |
| Hypertension | 1435 (31) |
| Dyspnea | 229 (4.9) |
| Current smoker | 742 (16) |
| Corticosteroid use | 80 (1.7) |
| Wound infection | 13 (0.3) |
| ASA physical status classification score | |
| 1—No disturbance | 217 (4.7) |
| 2—Mild disturbance | 2650 (57) |
| 3—Severe disturbance | 1744 (37) |
| 4—Life-threatening | 45 (1.0) |
| Wound class | |
| 1—Clean | 179 (3.8) |
| 2—Clean/contaminated | 4396 (94) |
| 3—Contaminated | 63 (1.4) |
| 4—Dirty/infected | 24 (0.5) |
| Functional Status | |
| Independent | 4606 (99) |
| Partially or totally dependent | 56 (1.2) |
ASA, American Society of Anesthesiology.
Table 2.
Surgical characteristics. Reported as n (%), unless otherwise stated.
| Characteristic | Patients (n = 4662) |
|---|---|
| Surgical specialty | |
| General | 39 (0.8) |
| ENT | 4587 (98) |
| Other | 36 (0.8) |
| Type of anesthesia | |
| General | 4642 (100) |
| Local | 3 (0.06) |
| Monitored anesthesia care | 8 (0.2) |
| Epidural or spinal | 6 (0.1) |
| Other or unknown | 3 (0.06) |
| Setting | |
| Inpatient | 1382 (30) |
| Outpatient | 3280 (70) |
| Year of surgery | |
| 2008 | 173 (3.7) |
| 2009 | 202 (4.3) |
| 2010 | 306 (6.6) |
| 2011 | 120 (2.6) |
| 2012 | 441 (9.5) |
| 2013 | 429 (9.2) |
| 2014 | 440 (9.4) |
| 2015 | 455 (9.8) |
| 2016 | 457 (9.8) |
| 2017 | 516 (11) |
| 2018 | 445 (9.5) |
| 2019 | 376 (8.1) |
| 2020 | 302 (6.5) |
Table 3.
(Sub)Types of surgery. Reported as n (%), unless otherwise stated.
| Type of Surgery | N of Patients (%) |
|---|---|
| Isolated Uvulopalatopharyngoplasty (UPPP) | 321 (6.9) |
| + tonsillectomy | 46 (1.0) |
| + turbinate reduction | 14 (0.3) |
| + tongue radiofrequency ablation (RFA) + tonsillectomy | 1 (0.02) |
| + turbinate reduction + tongue RFA | 3 (0.06) |
| + tongue RFA | 2 (0.04) |
| + turbinate reduction + tonsillectomy | 7 (0.2) |
| Isolated Palatopharyngoplasty (PPP) | 1161 (25) |
| + tonsillectomy | 887 (19) |
| + tonsillectomy + turbinate reduction | 306 (6.6) |
| + tonsillectomy + tongue RFA | 70 (1.5) |
| + tonsillectomy + turbinate reduction + tongue RFA | 43 (0.9) |
| + tonsillectomy + hyoid myotomy and suspension + turbinate reduction | 5 (0.1) |
| + turbinate reduction + sinus surgery | 27 (0.6) |
| + tongue RFA | 76 (1.6) |
| + turbinate reduction | 409 (8.8) |
| + sinus surgery | 22 (0.5) |
| + tonsillectomy + sinus surgery | 9 (0.2) |
| + turbinate reduction + tongue RFA | 41 (0.9) |
| + tonsillectomy + sinus surgery + turbinate reduction | 9 (0.2) |
| + tonsillectomy + turbinate reduction + sinus surgery + tongue RFA | 2 (0.04) |
| + turbinate reduction + sinus surgery + tongue RFA | 1 (0.02) |
| + sinus surgery + turbinate reduction + tonsillectomy | 2 (0.04) |
| + sinus surgery + tongue RFA | 1 (0.02) |
| + sinus surgery + tonsillectomy + tongue RFA | 1 (0.02) |
| Isolated Tonsillectomy | 578 (12) |
| + turbinate reduction | 85 (1.8) |
| + turbinate reduction + sinus surgery | 7 (0.2) |
| + uvulectomy | 76 (1.6) |
| + uvulectomy + sinus surgery | 2 (0.04) |
| + turbinate reduction + uvulectomy | 18 (0.4) |
| + uvulectomy + tongue RFA | 3 (0.06) |
| + turbinate reduction + tongue RFA | 1 (0.02) |
| + tongue RFA | 3 (0.06) |
| + sinus surgery | 2 (0.04) |
| Isolated Uvulectomy | 31 (0.7) |
| + turbinate reduction | 14 (0.3) |
| + sinus surgery + turbinate reduction | 2 (0.04) |
| + sinus surgery | 1 (0.02) |
| Isolated Partial Glossectomy | 13 (0.3) |
| + PPP | 35 (0.8) |
| + PPP + turbinate reduction | 6 (0.1) |
| + turbinate reduction | 4 (0.09) |
| + PPP + tonsillectomy | 28 (0.6) |
| + tonsillectomy + PPP + turbinate reduction | 7 (0.2) |
| + tonsillectomy + turbinate reduction | 3 (0.06) |
| + tonsillectomy | 2 (0.04) |
| + hyoid myotomy and suspension | 1 (0.02) |
| Isolated Genioglossus Advancement | 0 (0.0) |
| + maxillomandibular advancement | 15 (0.3) |
| + PPP + turbinate reduction | 1 (0.02) |
| + PPP + tonsillectomy | 3 (0.06) |
| + maxillomandibular advancement + sinus surgery + turbinate reduction | 1 (0.02) |
| + maxillomandibular advancement + PPP | 4 (0.09) |
| + maxillomandibular advancement + PPP + tonsillectomy | 2 (0.04) |
| + maxillomandibular advancement + PPP + turbinate reduction | 2 (0.04) |
| + maxillomandibular advancement + turbinate reduction | 1 (0.02) |
| + turbinate reduction | 1 (0.02) |
| + PPP | 1 (0.02) |
| Isolated Maxillomandibular Advancement | 25 (0.5) |
| Isolated Hyoid Myotomy and Suspension | 35 (0.8) |
| + tonsillectomy | 6 (0.1) |
| + PPP | 26 (0.6) |
| + tongue RFA | 3 (0.06) |
| + PPP + turbinate reduction | 10 (0.2) |
| + PPP + partial glossectomy | 1 (0.02) |
| + tongue RFA + turbinate reduction | 4 (0.09) |
| + PPP + tonsillectomy | 7 (0.2) |
| + PPP + tongue RFA | 2 (0.04) |
| + turbinate reduction | 1 (0.02) |
| Procedures Including Craniofacial Osteotomies | 32 (0.7) |
| Procedures Including Epiglottidectomy | 16 (0.3) |
| Procedures Including Tracheostomy | 18 (0.4) |
| Other | 57 (1.2) |
Table 4.
Operative and postoperative outcomes for all patients undergoing head and neck OSA surgery. Reported as n (%), unless otherwise stated.
Table 4.
Operative and postoperative outcomes for all patients undergoing head and neck OSA surgery. Reported as n (%), unless otherwise stated.
| Outcome | Patients (n = 4662) |
|---|---|
| Length of Hospital Stay, mean days ± SD | 0.9 ± 2.0 |
| Operative Time, mean minutes ± SD | 66 ± 54 |
| Any Complication | 292 (6.3) |
| Mortality within 30 days | 2 (0.04) |
| Reoperation | 163 (3.5) |
| Readmission | 100 (2.1) |
| Unplanned Readmission | 99 (2.1) |
| Surgical Complication | 48 (1.0) |
| Superficial Incisional Infection | 26 (0.6) |
| Deep Incisional Infection | 4 (0.09) |
| Organ-Space Infection | 8 (0.2) |
| Dehiscence | 10 (0.2) |
| Medical Complication | 55 (1.2) |
| Pneumonia | 21 (0.5) |
| Reintubation | 17 (0.4) |
| Pulmonary Embolism | 4 (0.09) |
| Ventilator > 48 h | 10 (0.2) |
| Myocardial Infarction | 1 (0.02) |
| Cardiac Arrest Requiring CPR | 1 (0.02) |
| DVT or Thrombophlebitis | 5 (0.1) |
| Urinary Tract Infection | 11 (0.2) |
| Septic Shock | 1 (0.02) |
| Sepsis | 8 (0.2) |
| Discharge destination | |
| Home | 3956 (85) |
| Not Home | 16 (0.3) |
| Other or Unknown | 8 (0.2) |
Table 5.
Distribution of procedures with the type-specific occurrence of any complication.
| Type of Surgery | Total | Any Complication | Any Complication (Total %) |
|---|---|---|---|
| Uvulopalatopharyngoplasty (UPPP), of which: | |||
| Isolated | 321 | 13 | 4.0 |
| + tonsillectomy | 46 | 3 | 6.5 |
| + turbinate reduction | 14 | 1 | 7.1 |
| + tongue radiofrequency ablation (RFA) | 2 | 0 | 0.0 |
| + turbinate reduction + tonsillectomy | 7 | 0 | 0.0 |
| + turbinate reduction + tongue RFA | 3 | 0 | 0.0 |
| + tongue RFA + tonsillectomy | 1 | 0 | 0.0 |
| Palatopharyngoplasty (PPP), of which: | |||
| Isolated | 1161 | 65 | 5.6 |
| + tonsillectomy | 887 | 57 | 6.4 |
| + tonsillectomy + turbinate reduction | 306 | 18 | 5.9 |
| + tonsillectomy + tongue RFA | 70 | 9 | 13 |
| + tonsillectomy + turbinate reduction + tongue RFA | 43 | 0 | 0.0 |
| + tonsillectomy + hyoid myotomy and suspension + turbinate reduction | 5 | 1 | 20 |
| + turbinate reduction + sinus surgery | 27 | 2 | 7.4 |
| + tongue RFA | 76 | 5 | 6.6 |
| + turbinate reduction | 409 | 18 | 4.4 |
| + sinus surgery | 22 | 0 | 0.0 |
| + tonsillectomy + sinus surgery | 9 | 2 | 22 |
| + turbinate reduction + tongue RFA | 41 | 4 | 9.8 |
| + tonsillectomy + sinus surgery + turbinate reduction | 9 | 1 | 11 |
| + tonsillectomy + turbinate reduction + sinus surgery + tongue RFA | 2 | 0 | 0.0 |
| + turbinate reduction + sinus surgery + tongue RFA | 1 | 0 | 0.0 |
| + sinus surgery + turbinate reduction + tonsillectomy | 2 | 0 | 0.0 |
| + sinus surgery + tongue RFA | 1 | 0 | 0.0 |
| + sinus surgery + tonsillectomy + tongue RFA | 1 | 0 | 0.0 |
| Tonsillectomy, of which: | |||
| Isolated | 578 | 50 | 8.7 |
| + turbinate reduction | 85 | 4 | 4.7 |
| + turbinate reduction + sinus surgery | 7 | 0 | 0.0 |
| + uvulectomy | 76 | 4 | 5.4 |
| + uvulectomy + sinus surgery | 2 | 0 | 0.0 |
| + turbinate reduction + uvulectomy | 18 | 2 | 11 |
| + uvulectomy + tongue RFA | 3 | 0 | 0.0 |
| + turbinate reduction + tongue RFA | 1 | 0 | 0.0 |
| + tongue RFA | 3 | 0 | 0.0 |
| + sinus surgery | 2 | 0 | 0.0 |
| Uvulectomy, of which: | |||
| Isolated | 31 | 0 | 0.0 |
| + turbinate reduction | 14 | 2 | 14 |
| + sinus surgery + turbinate reduction | 2 | 0 | 0.0 |
| + sinus surgery | 1 | 0 | 0.0 |
| Partial Glossectomy, of which: | |||
| Isolated | 13 | 0 | 0.0 |
| + PPP | 35 | 2 | 5.7 |
| + PPP + turbinate reduction | 6 | 1 | 17 |
| + turbinate reduction | 4 | 0 | 0.0 |
| + PPP + tonsillectomy | 28 | 3 | 11 |
| + tonsillectomy + PPP + turbinate reduction | 7 | 0 | 0.0 |
| + tonsillectomy + turbinate reduction | 3 | 0 | 0.0 |
| + tonsillectomy | 2 | 0 | 0.0 |
| + hyoid myotomy and suspension | 1 | 0 | 0.0 |
| Genioglossus Advancement, of which: | |||
| Isolated | 0 | 0 | 0.0 |
| + maxillomandibular advancement | 15 | 2 | 13 |
| + PPP + turbinate reduction | 1 | 0 | 0.0 |
| + PPP + tonsillectomy | 3 | 0 | 0.0 |
| + maxillomandibular advancement + sinus surgery + turbinate reduction | 1 | 0 | 0.0 |
| + maxillomandibular advancement + PPP | 4 | 0 | 0.0 |
| + maxillomandibular advancement + PPP + tonsillectomy | 2 | 1 | 50 |
| + maxillomandibular advancement + PPP + turbinate reduction | 2 | 1 | 50 |
| + maxillomandibular advancement + turbinate reduction | 1 | 0 | 0.0 |
| + turbinate reduction | 1 | 0 | 0.0 |
| + PPP | 1 | 0 | 0.0 |
| Isolated Maxillomandibular Advancement | 25 | 2 | 8.0 |
| Hyoid Myotomy and Suspension, of which: | |||
| Isolated | 35 | 3 | 8.6 |
| + tonsillectomy | 6 | 0 | 0.0 |
| + PPP | 26 | 3 | 12 |
| + tongue RFA | 3 | 0 | 0.0 |
| + PPP + turbinate reduction | 10 | 1 | 10 |
| + PPP + partial glossectomy | 1 | 0 | 0.0 |
| + tongue RFA + turbinate reduction | 4 | 1 | 25 |
| + PPP + tonsillectomy | 7 | 0 | 0.0 |
| + PPP + tongue RFA | 2 | 0 | 0.0 |
| + turbinate reduction | 1 | 0 | 0.0 |
| Procedures Including Craniofacial Osteotomies | 32 | 2 | 6.3 |
| Procedures Including Epiglottidectomy | 16 | 0 | 0.0 |
| Procedures Including Tracheostomy | 18 | 4 | 22 |
| Other | 57 | 5 | 8.8 |
Table 6.
Risk-associated factors for complications. Reported as n (%), unless otherwise stated. Statistically significant p-values are highlighted in bold.
Table 6.
Risk-associated factors for complications. Reported as n (%), unless otherwise stated. Statistically significant p-values are highlighted in bold.
| Any Complication | Surgical Complication | Medical Complication | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Yes (n = 292) | No (n = 4370) | p-Value | Yes (n = 48) | No (n = 4614) | p-Value | Yes (n = 55) | No (n = 4607) | p-Value |
| Demographics | |||||||||
| Sex | 0.03 | 0.20 | 0.36 | ||||||
| Female (n) | 64 (22) | 1209 (28) | 9 (19) | 1264 (27) | 18 (33) | 1255 (27) | |||
| Male (n) | 228 (78) | 3160 (72) | 39 (81) | 3349 (73) | 37 (67) | 3351 (73) | |||
| Age, mean ± SD | 41 ± 13 | 42 ± 13 | 0.44 | 46 ± 13 | 42 ± 13 | 0.04 | 45 ± 13 | 42 ± 13 | 0.05 |
| BMI, mean ± SD | 34 ± 8 | 33 ± 7 | 0.01 | 32 ± 6 | 33 ± 7 | 0.46 | 38 ± 9 | 33 ± 7 | <0.0001 |
| Race | 0.30 | 0.02 | 0.66 | ||||||
| American Indian or Alaskan Native | 2 (0.7) | 26 (0.6) | 0 (0) | 28 (0.1) | 0 (0) | 28 (0.6) | |||
| Asian | 23 (7.9) | 221 (5.1) | 2 (4.2) | 242 (5.2) | 3 (5.5) | 241 (5.2) | |||
| Native Hawaiian or Pacific Islander | 4 (1.4) | 47 (1.1) | 1 (2.1) | 50 (1.1) | 0 (0) | 51 (1.1) | |||
| Black or African American | 32 (11) | 512 (12) | 3 (6.3) | 541 (12) | 10 (18) | 534 (12) | |||
| White | 173 (59) | 2806 (64) | 23 (48) | 2956 (64) | 32 (58) | 2947 (64) | |||
| Other or unknown | 55 (19) | 749 (17) | 17 (35) | 787 (17) | 10 (18) | 794 (17) | |||
| Setting | <0.0001 | 0.0002 | <0.0001 | ||||||
| Outpatient | 167 (57) | 3113 (71) | 22 (46) | 3258 (71) | 24 (44) | 3256 (71) | |||
| Inpatient | 125 (43) | 1257 (29) | 26 (54) | 1356 (29) | 31 (56) | 1351 (29) | |||
| Preop health and comorbidities | |||||||||
| Diabetes | 45 (15) | 424 (9.7) | 0.002 | 6 (13) | 463 (10) | 0.48 | 15 (27) | 454 (9.9) | <0.0001 |
| Insulin-treated diabetes | 15 (5.1) | 122 (2.8) | 0.02 | 2 (4.2) | 135 (2.9) | 0.65 | 5 (9.1) | 132 (2.9) | 0.02 |
| COPD | 8 (2.7) | 52 (1.2) | 0.05 | 4 (8.3) | 56 (1.2) | 0.003 | 2 (3.6) | 58 (1.3) | 0.16 |
| CHF | 1 (0.3) | 4 (0.09) | 0.28 | 0 (0) | 5 (0.1) | >0.99 | 1 (1.8) | 4 (0.09) | 0.06 |
| Obesity | 195 (67) | 2714 (62) | 0.11 | 29 (60) | 2880 (62) | 0.78 | 45 (82) | 2864 (62) | 0.003 |
| Hypertension | 106 (36) | 1329 (30) | 0.03 | 18 (38) | 1417 (31) | 0.31 | 21 (38) | 1414 (31) | 0.23 |
| Dyspnea | 21 (7.2) | 208 (4.8) | 0.06 | 6 (13) | 223 (4.8) | 0.03 | 6 (11) | 223 (4.8) | 0.05 |
| Current smoker | 52 (18) | 690 (16) | 0.36 | 7 (15) | 735 (16) | >0.99 | 10 (18) | 732 (16) | 0.64 |
| Corticosteroid use | 7 (2.4) | 73 (1.7) | 0.35 | 2 (4.2) | 78 (1.7) | 0.20 | 4 (7.3) | 76 (1.6) | 0.01 |
| Wound infection | 2 (0.7) | 11 (0.3) | 1.19 | 0 (0) | 13 (0.3) | >0.99 | 1 (1.8) | 12 (0.3) | 0.14 |
| ASA physical status classification score | <0.0001 | 0.48 | 0.0006 | ||||||
| 1—No disturbance | 13 (4.5) | 204 (4.7) | 4 (8.3) | 213 (4.6) | 1 (1.8) | 216 (4.7) | |||
| 2—Mild disturbance | 149 (51) | 2501 (57) | 24 (50) | 2626 (57) | 19 (35) | 2631 (57) | |||
| 3—Severe disturbance | 119 (41) | 1625 (37) | 19 (40) | 1725 (37) | 33 (60) | 1711 (37) | |||
| 4—Life-threatening | 10 (3.4) | 35 (0.8) | 1 (2.1) | 44 (1.0) | 2 (3.6) | 43 (0.9) | |||
| Wound class | 0.81 | 0.82 | 0.22 | ||||||
| 1—Clean | 14 (4.8) | 165 (3.8) | 2 (4.2) | 177 (3.8) | 4 (7.3) | 175 (3.8) | |||
| 2—Clean/Contaminated | 272 (93) | 4124 (94) | 46 (96) | 4350 (94) | 50 (91) | 4346 (94) | |||
| 3—Contaminated | 4 (1.4) | 59 (1.4) | 0 (0) | 63 (1.4) | 0 (0) | 63 (1.4) | |||
| 4—Dirty/Infected | 2 (0.7) | 22 (0.5) | 0 (0) | 24 (0.5) | 1 (1.8) | 23 (0.5) | |||
| Functional Status | 0.08 | 0.44 | 0.03 | ||||||
| Independent | 285 (98) | 4321 (99) | 47 (98) | 4559 (99) | 52 (95) | 4554 (99) | |||
| Partially or totally dependent | 7 (2.4) | 49 (1.1) | 1 (2.1) | 55 (1.2) | 3 (5.5) | 53 (1.2) | |||
ASA, American Society of Anesthesiology.
Table 7.
Multivariable assessment of any, surgical, and medical complication occurrences for all patients undergoing head and neck OSA surgery.
Table 7.
Multivariable assessment of any, surgical, and medical complication occurrences for all patients undergoing head and neck OSA surgery.
| Risk-Associated Factors | OR | 95% CI | p-Value |
|---|---|---|---|
| Any complications | |||
| Sex (female) | −0.02 | −0.04–−0.01 | 0.003 |
| Diabetes | 0.03 | 0.00–0.05 | 0.03 |
| ASA physical status classification score (≥4) | 0.12 | 0.05–0.20 | 0.001 |
| Surgical complications | |||
| Race (White) | −0.02 | −0.02–−0.01 | <0.0001 |
| Race (Black or African American) | −0.02 | −0.03–−0.01 | 0.004 |
| COPD | 0.05 | 0.02–0.07 | 0.0006 |
| Medical complications | |||
| Diabetes | 0.02 | 0.01–0.03 | 0.003 |
| History of CHF | 0.15 | 0.05–0.24 | 0.004 |
| Corticosteroid use | 0.03 | 0.01–0.06 | 0.006 |
| Underweight; BMI < 18.5 | 0.08 | 0.01–0.14 | 0.02 |
| Extreme Obesity Class 3; BMI > 40 | 0.01 | 0.00–0.02 | 0.02 |
ASA, American Society of Anesthesiology.
Table 8.
Multivariable assessment of any, surgical, and medical complication occurrences with regard to different types of surgeries.
Table 8.
Multivariable assessment of any, surgical, and medical complication occurrences with regard to different types of surgeries.
| Risk-Associated Factors | OR | 95% CI | p-Value |
|---|---|---|---|
| Any complications | |||
| Isolated tonsillectomy | 0.05 | 0.02–0.09 | 0.003 |
| Procedures including tracheostomy | 0.12 | 0.00–0.25 | 0.04 |
| PPP + tonsillectomy + tongue RFA | 0.09 | 0.02–0.15 | 0.007 |
| PPP + tonsillectomy + sinus surgery | 0.17 | 0.01–0.33 | 0.03 |
| Genioglossus advancement + maxillomandibular advancement + PPP + tonsillectomy | 0.45 | 0.11–0.78 | 0.009 |
| Genioglossus advancement + maxillomandibular advancement + turbinate reduction | 0.96 | 0.48–1.43 | <0.0001 |
| Surgical complications | |||
| Genioglossus advancement + maxillomandibular advancement | 0.06 | 0.01–0.11 | 0.03 |
| Genioglossus advancement + maxillomandibular advancement + turbinate reduction | 0.99 | 0.79–1.18 | <0.0001 |
| Hyoid myotomy and suspension | 0.07 | 0.04–0.11 | <0.0001 |
| Hyoid myotomy and suspension + PPP | 0.06 | 0.02–0.10 | 0.001 |
| Hyoid myotomy and suspension + tongue RFA + turbinate reduction | 0.24 | 0.15–0.34 | <0.0001 |
| Medical complications | |||
| Procedures including tracheostomy | 0.06 | 0.00–0.11 | 0.04 |
| Genioglossus advancement + maxillomandibular advancement | 0.06 | 0.00–0.11 | 0.04 |
| PPP + tonsillectomy + tongue RFA | 0.03 | 0.00–0.06 | 0.04 |
| PPP + tonsillectomy + sinus surgery | 0.09 | 0.02–0.17 | 0.01 |
| PPP + tonsillectomy + sinus surgery + turbinate reduction | 0.11 | 0.03–0.18 | 0.004 |
| Hyoid myotomy and suspension + PPP + turbinate reduction | 0.09 | 0.02–0.16 | 0.01 |
| UPPP + turbinate reduction | 0.07 | 0.01–0.13 | 0.02 |
PPP: palatopharyngoplasty; RFA: radiofrequency ablation; UPPP, uvulopalatopharyngoplasty.
Table 9.
Preoperative lab values for complications. Statistically significant p-values are highlighted in bold.
Table 9.
Preoperative lab values for complications. Statistically significant p-values are highlighted in bold.
| Any Complication | Surgical Complication | Medical Complication | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Yes (n = 292) | No (n = 4370) | p-Value | Yes (n = 48) | No (n = 4614) | p-Value | Yes (n = 55) | No (n = 4607) | p-Value | Reference Range |
| Serum sodium (mmol/L) | 139.5 (2.7) | 139.4 (2.5) | 0.45 | 139.0 (3.2) | 139.4 (2.5) | 0.51 | 139.6 (2.3) | 139.4 (2.5) | 0.57 | 135–145 mmol/L |
| BUN (mg/dL) | 15.3 (8.3) | 15.1 (5.4) | 0.64 | 16.2 (4.8) | 15.1 (5.6) | 0.43 | 16.5 (12.0) | 15.1 (5.4) | 0.14 | 8–25 mg/dL |
| Creatinine (g/D) | 0.9 (0.5) | 1.0 (0.5) | 0.65 | 1.0 (0.3) | 1.0 (0.5) | 0.79 | 1.0 (0.5) | 1.0 (0.5) | 0.61 | F 0.6–1.8, M 0.8–2.4 g/D |
| Serum albumin (g/dL) | 4.2 (0.5) | 4.3 (0.4) | 0.38 | 4.3 (0.5) | 4.2 (0.4) | 0.78 | 4.1 (0.4) | 4.3 (0.4) | 0.16 | 3.1–4.3 g/dL |
| Total bilirubin (mg/dL) | 0.7 (0.9) | 0.6 (0.5) | 0.07 | 0.6 (0.3) | 0.6 (0.6) | 0.91 | 0.7 (0.5) | 0.6 (0.6) | 0.40 | 0–1 mg/dL |
| SGOT (U/L) | 28.4 (15.4) | 27.1 (25.5) | 0.68 | 20.0 (4.7) | 27.3 (25.0) | 0.35 | 25.3 (10.2) | 27.3 (25.1) | 0.74 | F 9–25, M 10–40 U/L |
| Alkaline phosphatase (U/L) | 81.5 (32.8) | 74.4 (23.5) | 0.02 | 70.3 (18.9) | 75.0 (24.3) | 0.57 | 94.1 (43.5) | 74.6 (23.7) | 0.001 | F 30–100 U/L |
| WBC × 103/mm3 | 7.8 (2.6) | 7.4 (2.8) | 0.09 | 7.2 (2.1) | 7.5 (2.8) | 0.66 | 8.1 (2.2) | 7.4 (2.8) | 0.15 | 4.5–11 × 103/mm3 |
| Hematocrit (% of RBCs) | 43.0 (4.9) | 42.8 (4.2) | 0.64 | 43.8 (3.9) | 42.8 (4.2) | 0.26 | 42.4 (4.5) | 42.8 (4.2) | 0.58 | F 36.0–46.0%, M 37.0–49.0% of RBCs |
| Platelet count × 103/µL | 248.2 (62.9) | 250.4 (64.3) | 0.68 | 240.7 (46.1) | 250.4 (64.4) | 0.48 | 242.3 (55.3) | 250.4 (64.4) | 0.47 | 130–400 × 103/µL |
| PTT (s) | 30.2 (3.7) | 29.3 (5.2) | 0.20 | 31.7 (4.7) | 29.4 (5.1) | 0.19 | 29.8 (4.7) | 29.4 (5.1) | 0.77 | 25–35 s |
| INR of PT values | 1.0 (0.1) | 1.0 (0.3) | 0.86 | 1.0 (0.1) | 1.0 (0.3) | 0.89 | 1.0 (0.1) | 1.0 (0.3) | 0.95 | <1.1 |
BUN, blood urea nitrogen; SGOT, serum glutamic-oxaloacetic transaminase; WBC, white blood cell; PTT, partial thromboplastin time; INR, international normalized ratio; PT, prothrombin time; s, seconds; SD, standard deviation; RBC, red blood cell.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Knoedler, S.; Knoedler, L.; Baecher, H.; Kauke-Navarro, M.; Obed, D.; Hoch, C.C.; Diehm, Y.F.; Vosler, P.S.; Harréus, U.; Kneser, U.; et al. 30-Day Postoperative Outcomes in Adults with Obstructive Sleep Apnea Undergoing Upper Airway Surgery. J. Clin. Med. 2022, 11, 7371. https://doi.org/10.3390/jcm11247371
AMA Style
Knoedler S, Knoedler L, Baecher H, Kauke-Navarro M, Obed D, Hoch CC, Diehm YF, Vosler PS, Harréus U, Kneser U, et al. 30-Day Postoperative Outcomes in Adults with Obstructive Sleep Apnea Undergoing Upper Airway Surgery. Journal of Clinical Medicine. 2022; 11(24):7371. https://doi.org/10.3390/jcm11247371
Chicago/Turabian StyleKnoedler, Samuel, Leonard Knoedler, Helena Baecher, Martin Kauke-Navarro, Doha Obed, Cosima C. Hoch, Yannick F. Diehm, Peter S. Vosler, Ulrich Harréus, Ulrich Kneser, and et al. 2022. "30-Day Postoperative Outcomes in Adults with Obstructive Sleep Apnea Undergoing Upper Airway Surgery" Journal of Clinical Medicine 11, no. 24: 7371. https://doi.org/10.3390/jcm11247371
APA StyleKnoedler, S., Knoedler, L., Baecher, H., Kauke-Navarro, M., Obed, D., Hoch, C. C., Diehm, Y. F., Vosler, P. S., Harréus, U., Kneser, U., & Panayi, A. C. (2022). 30-Day Postoperative Outcomes in Adults with Obstructive Sleep Apnea Undergoing Upper Airway Surgery. Journal of Clinical Medicine, 11(24), 7371. https://doi.org/10.3390/jcm11247371
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
